• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Drug-Device Combinations

Tandem Diabetes Care announces $200M notes offering

February 23, 2026 By Sean Whooley

Tandem Diabetes Care updated logo

This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here.   Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Funding Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Medtronic Diabetes to lay off 81 employees ahead of MiniMed separation

February 20, 2026 By Sean Whooley

Medtronic World Diabetes Day

Medtronic (NYSE:MDT) is cutting 81 jobs from its Diabetes unit ahead of its planned separation into MiniMed. A Worker Adjustment and Retraining Notification (WARN) notice filed in California confirms the company’s plans to lay off 81 employees at its Northridge facility. MedTech Dive reported the news first. The notice states that Medtronic notified the state of the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Medtronic, minimed

ICU Medical resolves Smiths Medical warning letter, posts mixed Q4

February 20, 2026 By Sean Whooley

This is the logo of ICU Medical.

ICU Medical (Nasdaq:ICUI) shares dipped slightly today on fourth-quarter results that were mixed compared to the consensus forecast. Shares of ICUI fell 1.25% to $149.74 apiece in early-morning trading today. The San Clemente, California-based infusion technology and critical care product provider reported losses of $15.7 million. That equals 64¢ per share on sales of $540.7 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Wall Street Beat Tagged With: ICU Medical, Smiths Medical

Tandem stock rises on Q4 beats, new pay-as-you-go model

February 19, 2026 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 11.5% to $20.65 apiece after the market closed today. The San Diego-based automated insulin delivery technology developer reported losses of 589 million. That equals 1¢ per share on sales of $290.4 […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

MGS opens new drug delivery device manufacturing facility

February 19, 2026 By drugdelivery

An exterior photo of the MGS manufacturing facility in Richfield, Wisconsin.

MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The medtech CDMO’s newest facility expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity. MGS said it developed the facility to support an unnamed global pharmaceutical company’s drug delivery platform. The site has 140,000 square […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: MGS

Sequel, Senseonics announce full launch of Eversense 365 CGM, twiist pump pairing

February 19, 2026 By Sean Whooley

Senseonics Eversense E3 CGM Sequel Med Tech twiist automated insulin delivery system

Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. Manchester, New Hampshire-based Sequel and Germantown, Maryland-based Senseonics now offer the Eversense 365 continuous glucose monitor (CGM) with the twiist automated insulin delivery (AID) system for people with type 1 diabetes in the U.S. The companies […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Technology Tagged With: Senseonics, Sequel Med Tech

InVera Medical wins European approval for vein infusion device

February 18, 2026 By Sean Whooley

InVera Medical Infusion Device

InVera Medical announced recently that it picked up European approval for its minimally invasive device for delivering vein treatments. The Galway, Ireland-based company designed its device to help deliver treatment more effectively to diseased leg veins, including varicose veins. CE mark approval enables the marketing of the InVera Infusion Device across the European Union. According […]

Filed Under: Drug-Device Combinations, Regulatory/Compliance, Vascular Tagged With: InVera Medical

Insulet stock rises before hours on Street-beating Q4, 31% sales growth

February 18, 2026 By Sean Whooley

Insulet logo

Insulet (Nasdaq:PODD) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD ticked up more than 8% to $266.10 apiece in morning trading today. The Acton, Massachusetts–based automated insulin delivery technology developer reported profits of $101.6 million. That equals $1.44 per share on sales of $783.8 […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Insulet

Beta Bionics sales grow 57% in Street-beating Q4, guidance set for 2026

February 17, 2026 By Sean Whooley

Beta Bionics Logo (1)

Beta Bionics (Nasdaq:BBNX) shares rose slightly after hours today on fourth-quarter results that topped the consensus forecast. Shares of BBNX ticked up about 1% to $14.10 apiece in post-market trading today. The Irvine, California-based automated insulin delivery system developer reported losses of $13.5 million. That equals 38¢ per share on sales of $32.1 million for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

Medtronic submits MiniMed Flex to FDA, Diabetes separation is on track amid strong Q4

February 17, 2026 By Sean Whooley

Medtronic Diabetes MiniMed Logo (1)

Medtronic (NYSE:MDT) said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system. On the company’s third-quarter earnings call, CFO Thierry Piéton explained the business’ performance as it works toward completing an IPO — for which it filed at the end of 2025 — and bringing […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic, minimed

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Interim pages omitted …
  • Page 374
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS